Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy

Institution(s): 
Blood Systems Research Institute UCSF
University of Pittsburgh
Approx. Sample Size to be Sequenced: 
597

Project:

Disease/Phenotype: 

sickle cell disease

PI: 
Mark Gladwin
NIH Program Officer: 
Starting Phase: 
Phase 2
Phases Involved: 
2
Co-PI: 
Yingze Zhang
Biorepository contact: 
Phenotype Liaison: 
Data Set contact(s): 
Short Name: 
walk_PHaSST
Sequencing Center(s) Phase 2: 
Baylor College of Medicine Human Genome Sequencing Center
Type of Sequencing: 
WGS
Sequencing External Funding: 
TOPMed Accession #: